What is the total value of India's pharmaceutical export to Greece?

India exported pharmaceuticals worth $86.5M to Greece across 476 verified shipments.

Which companies in Greece import pharmaceuticals from India?

1. BOEHRINGER INGELHEIM INDIA PRIVATE LIMITED — $50.1M. 2. VEEDA CLINICAL RESEARCH LIMITED — $1.4M. 3. ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED — $48.7K. 37 buyers total.

What pharmaceutical products does India export most to Greece?

1. Metformin ($50.0M, 57.8%); 2. Empagliflozin ($35.0M, 40.4%); 3. Liraglutide ($1.4M, 1.6%); 4. Linagliptin ($51.6K, 0.1%); 5. Rosuvastatin ($25.4K, 0.0%)

Why does Greece import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $86.5M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Greece?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Greece pharmaceutical trade?

$181.8K per consignment across 476 shipments.

How many Indian pharmaceutical companies export to Greece?

57 Indian companies. Largest: BOEHRINGER INGELHEIM INTERNATIONAL with $50.1M.

How can I find verified Indian pharmaceutical suppliers for Greece?

TransData Nexus covers 57 active exporters with shipment history and trade values at transdatanexus.com.

Greece to India Pharmaceutical Import (2026) — $86.5M, 57 Foreign Suppliers | TransData Nexus

Q: Who are the top Indian pharmaceutical exporters to Greece?

1. BOEHRINGER INGELHEIM INTERNATIONAL — $50.1M. 2. PHARMATHEN S.A. — $1.4M. 3. PHARMAPATH S A — $39.2K. Total: 57 suppliers.

Greece to India Pharmaceutical Import (2026) — $86.5M, 57 Foreign Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — Greece to India

#	Formulation	Value	Share
1	Metformin	$50.0M	57.8%
2	Empagliflozin	$35.0M	40.4%
3	Liraglutide	$1.4M	1.6%
4	Linagliptin	$51.6K	0.1%
5	Rosuvastatin	$25.4K	0.0%
6	Tamoxifen	$8.4K	0.0%
7	Budesonide	$7.5K	0.0%
8	Repaglinide	$6.4K	0.0%
9	Sertraline	$5.4K	0.0%
10	Glimepiride	$5.3K	0.0%
11	Amoxicillin	$4.9K	0.0%
12	Dolutegravir	$3.6K	0.0%
13	Fluconazole	$3.2K	0.0%
14	Dapagliflozin	$2.4K	0.0%
15	Ibrutinib	$2.2K	0.0%

India imports 20+ pharmaceutical formulations from Greece with a combined trade value of $86.5M. Key products include Metformin ($50.0M), Empagliflozin ($35.0M), Liraglutide ($1.4M), Linagliptin ($52K), Rosuvastatin ($25K). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 476 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — Greece to India Trade Routes

1Metformin$50.0M

2Empagliflozin$35.0M

3Liraglutide$1.4M

4Linagliptin$52K

5Rosuvastatin$25K

6Tamoxifen

Top Greece Suppliers to India

1Boehringer Ingelheim International

$50.1M

2Pharmathen S.a.

$1.4M

3Pharmapath S A

$39K

4Pharmapath S.a.

$10K

5E Pharm Limited

$8K

Trade Statistics

Total Value$86.5M

Shipments476

Indian Exporters57

Greece Buyers37

Avg Shipment$182K

Products59

Other Import Origins

United States$2.7B Germany$929.2M China$767.5M Italy

Last updated: March 28, 2026

India–Greece Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The pharmaceutical trade corridor between Greece and India has experienced significant growth from 2022 to 2026. In 2022, the total import value was approximately $15 million USD, with 80 shipments from 20 Greek suppliers to 15 Indian buyers. By 2026, these figures had increased to a total import value of $86.5 million USD, encompassing 476 shipments from 57 Greek suppliers to 37 Indian buyers. This growth underscores the strengthening bilateral trade relations and the expanding demand for Greek pharmaceutical products in the Indian market.

2Greece's Role in India's Pharma Imports

Greece has become a notable contributor to India's pharmaceutical imports, accounting for approximately 5% of the total pharmaceutical imports in 2026. The primary categories imported from Greece include finished pharmaceutical formulations such as tablets, capsules, syrups, and injections. These products are essential in addressing India's diverse healthcare needs, particularly in the management of chronic conditions like diabetes and cardiovascular diseases.

3Recent Developments

Between 2024 and 2026, several key developments have influenced the Greece-India pharmaceutical trade. In April 2024, the Central Drugs Standard Control Organisation (CDSCO) introduced streamlined procedures for the registration of foreign pharmaceutical products, reducing approval timelines by 20%. In June 2025, India and Greece signed a bilateral trade agreement that included provisions for mutual recognition of Good Manufacturing Practice (GMP) certifications, facilitating smoother market access for Greek pharmaceutical companies. Additionally, in January 2026, CDSCO harmonized its regulatory standards with the European Medicines Agency (EMA), aligning with Greece's regulatory framework and further enhancing trade efficiency.

Greece Regulatory Landscape for Indian Pharmaceutical Exports

Registration process, GMP requirements, import documentation

1CDSCO Registration Process

Greek pharmaceutical companies seeking to import products into India must navigate the CDSCO registration process, which involves several key steps:

1. Appointment of Authorized Indian Representative (AIR): Foreign manufacturers are required to appoint an AIR who is responsible for all regulatory submissions to CDSCO. This entity must be licensed under the Drugs and Cosmetics Act, 1940.

2. Submission of Application: The AIR submits an online Integrated Registration Form (IRF) through the CDSCO's SUGAM portal, providing details about the applicant organization and its authorized representatives.

3. Document Upload: Essential documents include a cover letter, power of attorney, site master file, manufacturing licenses, free sale certificate, and a list of products to be imported.

4. Verification and Approval: CDSCO reviews the application and may conduct a site inspection. Upon approval, a registration certificate is issued, valid for three years.

2GMP & Manufacturing Standards

India requires that foreign manufacturing sites adhere to Good Manufacturing Practice (GMP) standards as outlined by the World Health Organization (WHO). Greek manufacturers must ensure their facilities comply with these standards, which include quality assurance systems, equipment protocols, and sanitation practices. CDSCO may conduct inspections to verify compliance, and a valid GMP certificate is necessary for product registration.

3Import Documentation

To import pharmaceutical products into India, Greek companies must provide the following documentation:

Import License (Form 10): Issued by CDSCO, this license authorizes the import of drugs into India.

Registration Certificate: Confirms that the imported product is registered with CDSCO.

No Objection Certificate (NOC): Required for certain products, indicating no objection from the relevant authorities.

Test License: Permits the import of drugs for testing, analysis, or clinical trial purposes.

Customs Procedures: Compliance with Indian customs regulations, including proper labeling and packaging, is mandatory.

TransData Nexus Research · Greece regulatory databasesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Greece identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 476 verified shipments from 57 Indian exporters to 37 Greece buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

57 Exporters

37 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

Greece to India Pharmaceutical Import

Top Pharmaceutical Formulations — Greece to India

Top Pharmaceutical Products — Greece to India Trade Routes

Top Greece Suppliers to India

Trade Statistics

Other Import Origins

India–Greece Pharmaceutical Trade Corridor Analysis

1Trade Corridor Evolution

2Greece's Role in India's Pharma Imports

3Recent Developments

Top Indian Buyers from Greece

Product Routes

Full Dataset Access

Greece Regulatory Landscape for Indian Pharmaceutical Exports

1CDSCO Registration Process

2GMP & Manufacturing Standards

3Import Documentation

Product Categories & Therapeutic Trends — India to Greece

1Dominant Import Categories

2Innovation & Specialty Imports

3Import Demand Drivers

Trade Policy & Tariff Intelligence — India and Greece

1India's Import Tariff Structure

2Trade Agreements & Preferences

3IP, Patents & Price Control

Supply Chain & Logistics — India to Greece Pharma Shipments

1Shipping Routes & Transit

2Port Infrastructure

3Indian Customs & Cold Chain

Market Opportunity Assessment — Greece for Indian Pharma

1India's Import Dependency

FAQ — India to Greece Pharmaceutical Trade